Abstract
Background
Chronic hepatitis C virus (HCV) infection causes cirrhosis and hepatocellular carcinoma but is also etiologically linked to several extrahepatic medical conditions including renal disorders. HCV is also associated with extrahepatic malignancies and may be oncogenic. Whether HCV confers an increased risk of renal cell carcinoma (RCC) remains controversial.
Aims
Prospectively determine whether chronic HCV is associated with an increased risk of RCC.
Methods
At an integrated medical center in Detroit, Michigan, adult patients with suspected RCC or newly diagnosed colon cancer (controls) were screened for hepatitis C antibody (HCAB) and HCV RNA. Renal or colon cancers were confirmed histologically. The proportion of patients with HCAB and HCV RNA in each group was compared, and risk factors for renal cell carcinoma were determined by multivariable logistic regression analysis.
Results
RCC patients had a higher rate of HCAB positivity (11/140, 8 %) than colon cancer patients (1/100, 1 %) (p < 0.01). Of the HCAB-positive patients, 9/11 RCC and 0/1 controls had detectable HCV RNA. HCV RNA positivity was a significant risk factor for RCC (OR 24.20; 95 % CL 2.4, >999.9; p = 0.043). Additionally, viremic RCC patients were significantly younger than RCC patients who were HCV RNA negative (p = 0.013).
Conclusions
Patients with chronic HCV are at heightened risk of RCC.
Similar content being viewed by others
References
Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor disease in US Veterans with hepatitis C virus. JAMA. 2007;297:2010–2017.
Hartridege-Lambert SK, Stein EM, Markowitz AJ, Portlock CS. Hepatitis C and non-Hodgkin lymphoma: the clinical perspective. Hepatology. 2012;55:634–641.
Dalrymple LS, Koepsell T, Sampson J, et al. Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Neprhol. 2007;2:715–721.
Lipworth L, Tarone RE, McLaughlin JK, et al. The epidemiology of renal cell carcinoma. J Urol. 2006;176:2353–2358.
Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol. 2005;140:498–506.
Di Micco B, Di Micco P. HCV and renal cell carcinoma: a new insight between HCV and oncogenesis? Report of five cases. Exp Oncol. 2003;25:77–778.
Fayek S, Moore D, Bortecen KH, et al. Liver transplantation in the setting of extra-hepatic malignancy: two case reports. Transpl Proc. 2007;39:3512–3514.
Garcia JH, Coelho GR, Cavalcante FP, et al. Synchronous hepatocellular carcinoma and renal cell carcinoma in a liver transplant recipient: a case report. Transplantation. 2007;84:1713.
Rifkin SI. Thirty-seven uninterrupted years of hemodialysis: a case report. Medscape J Med. 2008;10:231.
Gordon SC, Moonka D, Brown KA, et al. Risk of renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomark Prev. 2010;19:1066–1073.
Hofmann JN, Torner A, Chow WH, Ye W, Purdue MP, Duberg AS. Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev. 2011;20:326–330.
Budakoglu B, Aksoy S, Arslan C, et al. Frequency of HCV infection in renal cell carcinoma patients. Med Oncol. 2012;29:1892–1895.
Lee MH, Yang HI, Lu SN, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469–477.
Allison R. Increased risk of non-liver cancer mortality in persons with chronic hepatitis C infection, Chronic Hepatitis Cohort Study (CHeCS), 2006–2010. [Abstract] 2014. Presented at the American College of Preventive Medicine Conference, New Orleans, LA.
Macleod LC, Hotaling JM, Wright JL, et al. Risk factors for renal cell carcinoma in the VITAL study. J Urol. 2013;190:1657–1661.
Omland LH, Farkas DK, Jepsen P, Obel N, Pedersen L. Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol. 2010;2:179–186.
Mahajan R, Xing J, Liu SJ, et al. Mortality among persons in care with hepatitis C virus infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006–2010. Clin Infect Dis. 2014;58:1055–1061.
Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, through 2002. Ann Intern Med. 2006;144:705–714.
Ditah I, Ditah F, Devaki P, et al. The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010. J Hepatol. 2014;60:691–698.
Finell L, Miller JT, Tokars JI, Alter MJ, Arduinos M. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial. 2005;18:52–61.
Fissell RB, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65:2335–2342.
Wiwanitkit V. Renal cell carcinoma and hepatitis C virus infection: Is there any cause-outcome relationship? Cancer Res Ther. 2011;7:226–227.
Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. J Urol. 2006;176:2397–2400.
Lee YC, Lee YL, Chuang JP, Lee JC. Difference in survival between colon and rectal cancer from SEER data. PLoS One. 2013;8:e78709.
Acknowledgments
The authors have received Grant support from Merck & Co.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gonzalez, H.C., Lamerato, L., Rogers, C.G. et al. Chronic Hepatitis C Infection as a Risk Factor for Renal Cell Carcinoma. Dig Dis Sci 60, 1820–1824 (2015). https://doi.org/10.1007/s10620-015-3521-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-015-3521-3